Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jacques Izopet and Nassim Kamar.
Jacques Izopet
Connection Strength
6.234
Nassim Kamar
  1. Should Persistent Hepatitis E Virus Replication in Transplant Patients Be Tolerated? Transplantation. 2018 02; 102(2):e84-e85.
    View in: PubMed
    Score: 0.753
  2. Ribavirin for chronic hepatitis E virus infection. N Engl J Med. 2014 06 19; 370(25):2447-8.
    View in: PubMed
    Score: 0.586
  3. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010 Mar 01; 50(5):e30-3.
    View in: PubMed
    Score: 0.435
  4. Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients. Transplantation. 2021 10 01; 105(10):e146-e147.
    View in: PubMed
    Score: 0.243
  5. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):322-323.
    View in: PubMed
    Score: 0.241
  6. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021 08 27; 36(9):1704-1709.
    View in: PubMed
    Score: 0.241
  7. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021 08 12; 385(7):661-662.
    View in: PubMed
    Score: 0.238
  8. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann Intern Med. 2021 09; 174(9):1336-1338.
    View in: PubMed
    Score: 0.237
  9. Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 06; 21(3):e13065.
    View in: PubMed
    Score: 0.204
  10. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transpl Infect Dis. 2019 04; 21(2):e13050.
    View in: PubMed
    Score: 0.202
  11. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 01; 70(1):206-209.
    View in: PubMed
    Score: 0.198
  12. Performance of a commercial assay for detecting and quantifying HEV RNA in faeces. J Clin Virol. 2018 12; 109:1-5.
    View in: PubMed
    Score: 0.197
  13. Diversity of hepatitis E virus genotype 3. Rev Med Virol. 2018 09; 28(5):e1987.
    View in: PubMed
    Score: 0.193
  14. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018 12; 38(12):2178-2189.
    View in: PubMed
    Score: 0.193
  15. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation. Transpl Infect Dis. 2018 Aug; 20(4):e12917.
    View in: PubMed
    Score: 0.193
  16. [Hepatitis E virus infection]. Rev Prat. 2018 Mar; 68(3):286-290.
    View in: PubMed
    Score: 0.189
  17. Hepatitis E virus infection. Nat Rev Dis Primers. 2017 Nov 16; 3:17086.
    View in: PubMed
    Score: 0.186
  18. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.185
  19. Rabbit Hepatitis E Virus Infections in Humans, France. Emerg Infect Dis. 2017 07; 23(7):1191-1193.
    View in: PubMed
    Score: 0.181
  20. Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study. Transpl Infect Dis. 2017 Aug; 19(4).
    View in: PubMed
    Score: 0.181
  21. Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France. Emerg Infect Dis. 2017 02; 23(2):353-356.
    View in: PubMed
    Score: 0.176
  22. Hepatitis C virus and kidney disease. Clin Res Hepatol Gastroenterol. 2013 Sep; 37(4):328-33.
    View in: PubMed
    Score: 0.134
  23. Treatment of hepatitis C virus infection after kidney transplantation. Contrib Nephrol. 2012; 176:87-96.
    View in: PubMed
    Score: 0.124
  24. [Cytomegalovirus effects in solid organ transplantation and the role of antiviral prophylaxis]. Nephrol Ther. 2010 Nov; 6(6):505-12.
    View in: PubMed
    Score: 0.113
  25. Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021 09 01; 105(9):e94-e95.
    View in: PubMed
    Score: 0.060
  26. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021 10; 100(4):915-927.
    View in: PubMed
    Score: 0.059
  27. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 2019 07 09; 11(7).
    View in: PubMed
    Score: 0.052
  28. Transfusion-Transmitted Hepatitis E Virus Infection in France. Transfus Med Rev. 2019 07; 33(3):146-153.
    View in: PubMed
    Score: 0.052
  29. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018 10; 94(4):663-673.
    View in: PubMed
    Score: 0.049
  30. Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018 09; 77(3):220-226.
    View in: PubMed
    Score: 0.049
  31. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology. 2017 Aug 29; 89(9):909-917.
    View in: PubMed
    Score: 0.045
  32. Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. J Hepatol. 2017 11; 67(5):925-932.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.